Personalized nutrition support in critical care has emerged as a pivotal aspect of modern intensive care, aiming to optimize patient outcomes through individualized nutritional assessment and targeted interventions. Recent advances in metabolic monitoring, molecular profiling, and guideline-based approaches have enabled a shift from traditional, standardized feeding protocols to evidence-driven, patient-centric nutritional strategies. This review synthesizes contemporary literature, elucidates the pathophysiological rationale for tailored nutrition in critically ill patients, and provides practical insights for clinicians seeking to implement best practices in ICU nutrition support.
Critical illness triggers profound metabolic and physiological changes, markedly influencing nutritional requirements and clinical outcomes. Malnutrition and inappropriate feeding in the intensive care unit (ICU) are associated with increased morbidity, prolonged hospital stays, and higher mortality. Traditional nutrition protocols often fail to account for individual variability in metabolic response, organ function, or comorbidities. The concept of personalized nutrition support, guided by detailed assessments and real-time metabolic data, is gaining traction as a means to optimize care for critically ill patients. This article provides a comprehensive overview of the epidemiology, underlying mechanisms, risk factors, clinical presentation, diagnostic approaches, management strategies, and evolving guidelines for personalized nutrition support in critical care.
Malnutrition remains prevalent among ICU patients, with rates ranging from 30% to 60% depending on patient populations and assessment criteria. Critically ill patients are particularly susceptible to rapid nutritional depletion due to hypercatabolism, reduced oral intake, and increased energy expenditure. Suboptimal nutrition support is linked to poor wound healing, immunosuppression, increased infection rates, and higher mortality. Epidemiological studies indicate that individualized nutrition interventions can reduce complications and improve recovery trajectories, highlighting the clinical burden and unmet needs in this domain.
Critical illness induces a complex cascade of metabolic alterations, including insulin resistance, proteolysis, lipolysis, and altered substrate utilization. The stress response, driven by inflammatory cytokines, catecholamines, and cortisol, leads to increased energy demands and rapid muscle wasting. However, these changes vary considerably among patients based on genetic predisposition, age, pre-existing nutritional status, and type of critical illness (e.g., sepsis, trauma, burns). Understanding the pathophysiology of these metabolic disturbances is essential for designing personalized nutrition regimens that address both macronutrient and micronutrient requirements.
Key risk factors for malnutrition and suboptimal nutrition support in critically ill patients include advanced age, pre-existing chronic illnesses (such as chronic kidney disease or heart failure), baseline malnutrition, obesity, gastrointestinal dysfunction, and prolonged mechanical ventilation. Additional considerations such as pharmacological interventions (e.g., corticosteroids, vasopressors), organ dysfunction, and the presence of systemic inflammation further complicate nutritional management. Identification and stratification of these risk factors are fundamental for the development of effective, individualized nutrition plans.
Clinical manifestations of malnutrition in the ICU may be subtle or overt, ranging from muscle wasting, weight loss, and hypoalbuminemia, to more severe consequences such as impaired wound healing, increased susceptibility to infections, and multi-organ dysfunction. Tools such as the Subjective Global Assessment (SGA) and Nutrition Risk in the Critically Ill (NUTRIC) score facilitate the identification of patients at high risk for poor nutrition-related outcomes, thereby informing the need for personalized interventions.
Diagnosis of nutritional status in critically ill patients incorporates a combination of clinical assessment, anthropometric measurements, laboratory markers, and indirect calorimetry. Recent advances include metabolic cart technology for real-time measurement of energy expenditure, bioelectrical impedance analysis for body composition, and emerging biomarkers of inflammation and protein catabolism. Accurate diagnosis is critical for tailoring nutrition support to individual needs, avoiding both underfeeding and overfeeding.
Personalized nutrition support encompasses individualized assessment of energy requirements, macronutrient and micronutrient needs, and mode of delivery (enteral vs. parenteral). Early enteral nutrition is generally preferred in hemodynamically stable patients, while parenteral nutrition is reserved for those with contraindications to enteral feeding. Energy and protein targets should be adjusted based on disease severity, metabolic response, and ongoing monitoring of nutritional and clinical parameters. Regular reassessment and multidisciplinary collaboration are essential to adapt nutrition plans as patient condition evolves.
Emerging technologies such as continuous metabolic monitoring, nutrigenomics, and microbiome analysis are revolutionizing personalized nutrition support in the ICU. Recent clinical trials have demonstrated the feasibility and benefit of indirect calorimetry-guided feeding, while pharmacological modulation of metabolism (e.g., anabolic agents, immunonutrition) holds promise for specific patient populations. Integration of artificial intelligence and predictive analytics may further refine individualized nutrition strategies, optimizing outcomes through data-driven decision support.
Leading societies, including the European Society for Clinical Nutrition and Metabolism (ESPEN) and the American Society for Parenteral and Enteral Nutrition (ASPEN), emphasize the importance of early nutrition assessment, regular reassessment, and individualized energy/protein targets in critically ill patients. Guidelines advocate for the preferential use of enteral nutrition, avoidance of overfeeding, and incorporation of metabolic monitoring where feasible. The adoption of risk stratification tools and multidisciplinary nutrition support teams is strongly recommended to ensure best practices in personalized care.
Personalized nutrition support in critical care represents a paradigm shift from standardized protocols to patient-centered, evidence-based interventions. By integrating metabolic, clinical, and individual patient characteristics, clinicians can optimize nutritional therapy, enhance recovery, and reduce complications in the ICU. Ongoing research and technological innovation continue to expand the frontiers of personalized nutrition, offering new opportunities for improving outcomes in this complex patient population.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation